Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

doterra australia pty ltd - astaxanthin esters extracted from haematococcus pluvialis,betacarotene,borago officinalis,colecalciferol,concentrated fish omega-3 triglycerides,caraway oil,chamomile oil german,cumin oil,d-alpha-tocopherol,ginger oil,lutein,lycopene,olibanum oil,orange oil,peppermint oil,punica granatum,syzygium aromaticum,thyme oil,zeaxanthin -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

the juice plus company australia pty ltd - astaxanthin esters extracted from haematococcus pluvialis,amylase,ananas comosus,beta vulgaris,betacarotene,bromelains,calcium ascorbate dihydrate,cellulase,carica papaya,citrus bioflavonoids extract,citrus limon,citrus sinensis,citrus x paradisi,d-alpha-tocopherol,folic acid,lutein,lactobacillus acidophilus,lipase,lycopene,mixed (high-alpha type) tocopherols concentrate,malpighia glabra,malus domestica,papain,phoenix dactylifera,protease,prunus domestica,prunus persica,vaccinium macrocarpon -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

the juice plus company australia pty ltd - astaxanthin esters extracted from haematococcus pluvialis,allium sativum,amylase,arthrospira platensis,avena sativa,betacarotene,beta vulgaris,brassica oleracea var. capitata,brassica oleracea var. italica,brassica oleracea var. viridis,calcium ascorbate dihydrate,calcium carbonate,cellulase,d-alpha-tocopherol,daucus carota,folic acid,lipase,lutein,lycopene,lactobacillus acidophilus,lycopersicon esculentum,mixed (high-alpha type) tocopherols concentrate,oryza sativa,petroselinum crispum,protease -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

the juice plus company australia pty ltd - astaxanthin esters extracted from haematococcus pluvialis,amylase,ananas comosus,beta vulgaris,betacarotene,bromelains,calcium ascorbate dihydrate,cellulase,carica papaya,citrus bioflavonoids extract,citrus limon,citrus sinensis,citrus x paradisi,d-alpha-tocopherol,folic acid,lutein,lactobacillus acidophilus,lipase,lycopene,mixed (high-alpha type) tocopherols concentrate,malpighia glabra,malus domestica,papain,phoenix dactylifera,protease,prunus domestica,prunus persica,vaccinium macrocarpon -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

the juice plus company australia pty ltd - astaxanthin esters extracted from haematococcus pluvialis,allium sativum,amylase,arthrospira platensis,avena sativa,beta vulgaris,betacarotene,brassica oleracea var. capitata,brassica oleracea var. italica,brassica oleracea var. viridis,calcium ascorbate dihydrate,cellulase,calcium carbonate,d-alpha-tocopherol,daucus carota,folic acid,lutein,lactobacillus acidophilus,lipase,lycopene,lycopersicon esculentum,mixed (high-alpha type) tocopherols concentrate,oryza sativa,petroselinum crispum,protease -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

eris pharmaceuticals (australia) pty ltd - astaxanthin esters extracted from haematococcus pluvialis -

Spojené štáty - angličtina - NLM (National Library of Medicine)

natural creations, inc - alopecurus pratensis (unii: t306u9v415) (alopecurus pratensis - unii:t306u9v415), anthoxanthum odoratum whole (unii: ymw1k70e4q) (anthoxanthum odoratum - unii:ymw1k70e4q), cynodon dactylon whole (unii: 2q8mr21nhk) (cynodon dactylon whole - unii:2q8mr21nhk), melilotus officinalis top (unii: gm6p02j2dx) (melilotus officinalis top - unii:gm6p02j2dx), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense top - unii:s7pw24bx20), rumex crispus root (unii: 9n1rm2s62c) (rumex crispus root - unii:9n1rm2s6 - uses: temporarily relives symptoms related to weed & grass allergies.** uses: temporarily relives symptoms related to weed & grass allergies.**

Spojené štáty - angličtina - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 1000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

Spojené štáty - angličtina - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 20000 [bau] in 1 ml - indicated use of allergenic extracts is for the diagnosis and treatment (hyposensitization therapy) of patients who experience allergic symptoms due to exposure to grass pollen and who exhibit type i skin sensitivity when tested to those specific allergens. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants in situations where the offending allergen cannot be avoided. for previously untreated patients, prior to the initiation of therapy, clinical sensitivity to the standardized grass pollen extract should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. 10,000 bau/ml extracts are indicated for percutaneous testing. if negative, the 100,000 bau/ml dose may be used. availability of 10,000 and 100,000 bau/ml dosages facilitate safe

Spojené štáty - angličtina - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 20000 [bau] in 1 ml - indicated use of allergenic extracts is for the diagnosis and treatment (hyposensitization therapy) of patients who experience allergic symptoms due to exposure to grass pollen and who exhibit type i skin sensitivity when tested to those specific allergens. hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants in situations where the offending allergen cannot be avoided. for previously untreated patients, prior to the initiation of therapy, clinical sensitivity to the standardized grass pollen extract should be established by careful evaluation of the patient's history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. 10,000 bau/ml extracts are indicated for percutaneous testing. if negative, the 100,000 bau/ml dose may be used. availability of 10,000 and 100,000 bau/ml dosages facilitate safe